Acer Therapeutics to Present at UBS Global Healthcare Conference
May 07, 2019 08:30 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious...
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
April 16, 2019 08:30 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
March 13, 2019 11:17 ET
|
Acer Therapeutics Inc.
In a release issued earlier today by Acer Therapeutics Inc. (Nasdaq: ACER), please note in the table for the Roth Capital Partners 31st Annual Growth Stock Conference, a time of 3:30 pm Pacific Time...
Acer Therapeutics to Participate in Upcoming Investor Conferences
March 13, 2019 08:30 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
March 07, 2019 16:01 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
Acer Therapeutics Announces In-license of Osanetant from Sanofi
January 02, 2019 08:30 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...
Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
December 26, 2018 08:30 ET
|
Acer Therapeutics Inc.
Acer continues progress toward goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the...
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
December 17, 2018 08:30 ET
|
Acer Therapeutics Inc.
Seasoned veteran brings two decades of commercial experience to Acer Acer continues to execute on activities towards its goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 17, 2018 (GLOBE...
Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 09, 2018 16:01 ET
|
Acer Therapeutics Inc.
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Corporate Development and IT & Database Administrator NEWTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE)...
Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
November 08, 2018 08:30 ET
|
Acer Therapeutics Inc.
NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for...